Pages that link to "Q36119574"
Jump to navigation
Jump to search
The following pages link to Neurological disorders and therapeutics targeted to surmount the blood–brain barrier (Q36119574):
Displaying 18 items.
- Nanoparticles for brain drug delivery (Q21285117) (← links)
- Nanotechnology in neurology: Genesis, current status, and future prospects (Q26771772) (← links)
- Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines (Q26850868) (← links)
- Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements (Q30393215) (← links)
- Drug delivery systems, CNS protection, and the blood brain barrier (Q30432845) (← links)
- Current approaches to enhance CNS delivery of drugs across the brain barriers (Q30437835) (← links)
- Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging (Q30924405) (← links)
- Bioactive marine drugs and marine biomaterials for brain diseases (Q33736687) (← links)
- Nanoformulated cell-penetrating survivin mutant and its dual actions (Q33904982) (← links)
- Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain (Q37351380) (← links)
- The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases (Q38550131) (← links)
- Dual agents loaded polymeric nanoparticle: Effect of process variables (Q38844946) (← links)
- Transendothelial Transport and Its Role in Therapeutics (Q38880426) (← links)
- Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain (Q44610359) (← links)
- Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats (Q52148832) (← links)
- In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases. (Q53697270) (← links)
- Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management (Q57169956) (← links)
- Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis (Q96305499) (← links)